Forging Partnerships for a Better Tomorrow at the Grantmakers In Health Annual Conference
The Grantmakers In Health Annual Conference pre-conference sessions kicked off today in New Orleans, a city rich in resilience and spirit. Nearly 20 years since Hurricane Katrina, we gather to be inspired by the partnerships that supported communities two decades ago, and the ones that we are forging for the road ahead.
Infosheet: Key Provisions in the House-passed Reconciliation Bill—H.R. 1, the ‘One Big Beautiful Bill Act’
An infosheet provides analysis of key health, philanthropy, and nonprofit provisions in H.R. 1, the budget reconciliation bill passed by the U.S. House of Representatives on May 22, 2025. Changes include an estimated $715 billion reduction in federal Medicaid spending including work requirements, new eligibility requirements to the Affordable Care Act that will reduce access to the ACA’s Advanced Premium Tax Credits, $300 billion in reductions to Supplemental Nutrition Assistance Program (SNAP) benefits, an excise tax on foundations, and new authority for the Secretary of the Treasury to remove the tax-exempt status of nonprofits the administration deems as “terrorist support organizations.”
Philanthropy @ Work – Grants and Programs – May 2025
The latest on grants and programs from the field.
Power to the People: Advancing Impact Through Participatory Budgeting
Who is best positioned to determine how health funding should be allocated? At the Community Health Commission of Missouri (CHCM), we believe the answer is clear: the people most affected by health disparities.
How Pew Is Learning to Improve Health Policy
Antibiotics revolutionized medical treatment and are a cornerstone of modern health care. However, the global rise of antibiotic-resistant bacteria is making infections costlier and deadlier. After a 2008 report commissioned by The Pew Charitable Trusts highlighted these concerns, the organization invested in multiple projects to set limits on the use of antibiotics and to spur the development of new drugs.